Antigen Location Contributes to the Pathological Features of a Transplanted Heart Graft

American Journal of Pathology

Volumn 164, Issue 4, 2004, Pages 1407-1415

  Chen, Yifa ^a   Demir, Yilmaz ^a   Valujskikh, Anna ^a   Heeger, Peter S ^a,b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CD4 ANTIGEN; CYTOKINE; LYMPHOCYTE SURFACE MARKER; T LYMPHOCYTE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CHRONIC GRAFT REJECTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HEART GRAFT; HEART TRANSPLANTATION; IMMUNOPATHOLOGY; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MONONUCLEAR CELL; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TRANSGENIC MOUSE;

EID: 1642266513     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)63227-0     Document Type: Article

References (54)

1. Ingulli E, Mondino A, Khoruts A, Jenkins MK: In vivo detection of dendritic cell antigen presentation to CD4(+) T cells. J Exp Med 1997, 185:2133-2141
2. Jenkins MK, Khoruts A, Ingulli E, Mueller DL, McSorley SJ, Reinhardt RL, Itano A, Pape KA: In vivo activation of antigen-specific CD4 T cells. Annu Rev Immunol 2001, 19:23-45
3. Lakkis FG, Arakelov A, Konieczny BT, Inoue Y: Immunologic 'ignorance' of vascularized organ transplants in the absence of secondary lymphoid tissue. Nat Med 2000, 6:686-688
4. Bluestone JA: Costimulation and its role in organ transplantation. Clin Transplant 1996, 10:104-109
5. Stoll S, Delon J, Brotz TM, Germain RN: Dynamic imaging of T cell-dendritic cell interactions in lymph nodes. Science 2002, 296: 1873-1876
6. Sprent J, Surh CD: T cell memory. Annu Rev Immunol 2002, 20:551-579
7. Reinhardt RL, Khoruts A, Merica R, Zell T, Jenkins MK: Visualizing the generation of memory CD4 T cells in the whole body. Nature 2001, 410:101-105
8. Masopust D, Vezys V, Marzo AL, Lefrancois L: Preferential localization of effector memory cells in nonlymphoid tissue. Science 2001, 291:2413-2417
9. Kaech SM, Wherry EJ, Ahmed R: Effector and memory T-cell differentiation: implications for vaccine development. Nat Rev Immunol 2002, 2:251-262
10. Sallusto F, Mackay CR, Lanzavecchia A: The role of chemokine receptors in primary, effector, and memory immune responses. Annu Rev Immunol 2000, 18:593-620
11. Rossi D, Zlotnik A: The biology of chemokines and their receptors. Annu Rev Immunol 2000, 18:217-242
12. el-Sawy T, Fahmy NM, Fairchild RL: Chemokines: directing leukocyte infiltration into allografts. Curr Opin Immunol 2002, 14:562-568
13. Rehermann B: Interaction between the hepatitis C virus and the immune system. Semin Liver Dis 2000, 20:127-141
14. Thomsen AR, Nansen A, Andreasen SO, Wodarz D, Christensen JP: Host factors influencing viral persistence. Philos Trans R Soc Lond B Biol Sci 2000, 355:1031-1041
15. Frisk G: Mechanisms of chronic enteroviral persistence in tissue. Curr Opin Infect Dis 2001, 14:251-256
16. Bolton EM, Armstrong HE, Briggs JD, Bradley JA: Cellular requirements for first-set renal allograft rejection. Transplant Proc 1987, 19:321-323
17. Bolton EM, Gracie JA, Briggs JD, Kampinga J, Bradley JA: Cellular requirements for renal allograft rejection in the athymic nude rat. J Exp Med 1989, 169:1931-1946
18. Jones ND, Turvey SE, Van Maurik A, Hara M, Kingsley CI, Smith CH, Mellor AL, Morris PJ, Wood KJ: Differential susceptibility of heart, skin, and islet allografts to T cell-mediated rejection. J Immunol 2001, 166:2824-2830
19. Vella JP, Magee C, Vos L, Womer K, Rennke H, Carpenter CB, Hancock W, Sayegh MH: Cellular and humoral mechanisms of vascularized allograft rejection induced by indirect recognition of donor MHC allopeptides. Transplantation 1999, 67:1523-1532
20. Valujskikh A, Pantenburg B, Heeger PS: Primed allospecific T cells prevent the effects of costimulatory blockade on prolonged cardiac allograft survival in mice. Am J Transplant 2002, 2:501-509
21. Valujskikh A, Fedoseyeva E, Benichou G, Heeger PS: Development of autoimmunity after skin graft rejection via an indirect alloresponse. Transplantation 2002, 73:1130-1137
22. Subramanian SV, Orosz CG, Strauch AR: Vascular smooth muscle alpha-actin expression as an indicator of parenchymal cell reprogramming in cardiac allografts. Transplantation 1998, 65:1652-1656
23. Armstrong AT, Strauch AR, Starling RC, Sedmak DD, Orosz CG: Morphometric analysis of neointimal formation in murine cardiac grafts: III. Dissociation of interstitial fibrosis from neointimal formation. Transplantation 1997, 64:1198-1202
24. Ardehali A, Fischbein MP, Yun J, Irie Y, Fishbein MC, Laks H: Indirect alloreactivity and chronic rejection. Transplantation 2002, 73:1805-1807
25. Kist-van Holthe JE, Gasser M, Womer K, Najafian N, Dong V, Samsonov DV, Geehan CS, Chandraker A, Sayegh MH, Waaga AM: Regulatory functions of alloreactive Th2 clones in human renal transplant recipients. Kidney Int 2002, 62:627-631
26. Hancock WW, Sayegh MH, Carpenter CB: In vivo evidence for the Th1/Th2 paradigm: oral alloantigen-induced modulation of accelerated allograft rejection is associated with dense intragraft IL-4. Transplant Proc 1992, 24:2313-2314
27. Onodera K, Hancock WW, Graser E, Lehmann M, Sayegh MH, Strom TB, Volk HD, Kupiec-Weglinski JW: Type 2 helper T cell-type cytokines and the development of "infectious" tolerance in rat cardiac allograft recipients. J Immunol 1997, 158:1572-1581
28. VanBuskirk AM, Wakely ME, Orosz CG: Transfusion of polarized TH2-like cell populations into SCID mouse cardiac allograft recipients results in acute allograft rejection. Transplantation 1996, 62:229-238
29. VanBuskirk AM, Wakely ME, Orosz CG: Acute rejection of cardiac allografts by noncytolytic CD4(+) T cell populations. Transplantation 1996, 62:300-302
30. VanBuskirk AM, Wakely ME, Sirak JH, Orosz CG: Patterns of allosensitization in allograft recipients: long-term cardiac allograft acceptance is associated with active alloantibody production in conjunction with active inhibition of alloreactive delayed-type hypersensitivity. Transplantation 1998, 65:1115-1123
31. Matesic D, Lehmann PV, Heeger PS: High-resolution characterization of cytokine-producing alloreactivity in naive and allograft-primed mice. Transplantation 1998, 65:906-914
32. Matesic D, Valujskikh A, Pearlman E, Higgins AW, Gilliam AC, Heeger PS: Type 2 immune deviation has differential effects on alloreactive CD4+ and CD8+ T cells. J Immunol 1998, 161:5236-5244
33. Lappe MA, Graff RG, Snell GD: The importance of target size in the destruction of skin grafts with non-H-2 incompatibility. Transplantation 1969, 7:372-377
34. Simpson E, Scott D, Chandler P: The male-specific histocompatibility antigen, H-Y: a history of transplantation, immune response genes, sex determination and expression cloning. Annu Rev Immunol 1997, 15:39-61
35. Benichou G, Valujskikh A, Heeger PS: Contributions of direct and indirect T cell alloreactivity during allograft rejection in mice. J Immunol 1999, 162:352-358
36. Lee RS, Yamada K, Houser SL, Womer KL, Maloney ME, Rose HS, Sayegh MH, Madsen JC: Indirect recognition of allopeptides promotes the development of cardiac allograft vasculopathy. Proc Natl Acad Sci USA 2001, 98:3276-3281
37. Yamada A, Laufer TM, Gerth AJ, Chase CM, Colvin RB, Russell PS, Sayegh MH, Auchincloss Jr H: Further analysis of the T-cell subsets and pathways of murine cardiac allograft rejection. Am J Transplant 2003, 3:23-27
38. Valuiskikh A, Lantz O, Celli S, Matzinger P, Heeger PS: Cross-primed CD8(+) T cells mediate graft rejection via a distinct effector pathway. Nat Immunol 2002, 3:844-851
39. Silvers WK, Billingham RE, Sanford BH: The H-Y transplantation antigen: a Y-linked or sex-influenced factor? Nature 1968, 220:401-403
40. Silvers WK, Collins NH: The behavior of H-Y-incompatible neonatal skin grafts in rats. Transplantation 1979, 28:57-59
41. Wang W, Meadows LR, den Haan JM, Sherman NE, Chen Y, Blokland E, Shabanowitz J, Agulnik AI, Hendrickson RC, Bishop CE, Hunt DF, Goulmy E, Engelhard VH: Human H-Y: a male-specific histocompatibility antigen derived from the SMCY protein. Science 1995, 269: 1588-1590
42. Braun MY, Grandjean I, Feunou P, Duban L, Kiss R, Goldman M, Lantz O: Acute rejection in the absence of cognate recognition of allograft by T cells. J Immunol 2001, 166:4879-4883
43. Armstrong A, Strauch A, Starling R, Sedmak D, Orosz C: Morphometric analysis of neointimal proliferation in murine cardiac allografts. Transplantation 1997, 63:941-947
44. Herskowitz A, Tamura F, Ueda K, Neumann DA, Stepian M, Rose NR, Beschorner WE, Baumgartner WA, Reitz BR, Sell KW, Ahmed-Ansari A: Induction of donor major histocompatibility complex antigens in coronary arterial vessels: mechanism of arterial vasculitis in rat allografts treated with cyclosporine. J Heart Transplant 1989, 8:11-19
45. Isobe M, Narula J, Southern JF, Strauss HW, Khaw BA, Haber E: Imaging the rejecting heart. In vivo detection of major histocompatibility complex class II antigen induction. Circulation 1992, 85:738-746
46. Wang YC, Herskowitz A, Gu LB, Kanter K, Lattouf O, Sell KW, Ahmed-Ansari A: Influence of cytokines and immunosuppressive drugs on major histocompatibility complex class I/II expression by human cardiac myocytes in vitro. Hum Immunol 1991, 31:123-133
47. Tellides G, Tereb DA, Kirkiles-Smith NC, Kim RW, Wilson JH, Schechner JS, Lorber MI, Pober JS: Interferon-gamma elicits arteriosclerosis in the absence of leukocytes. Nature 2000, 403:207-211
48. Savinov AY, Wong FS, Stonebraker AC, Chervonsky AV: Presentation of antigen by endothelial cells and chemoattraction are required for homing of insulin-specific CD8+ T cells. J Exp Med 2003, 197:643-656
49. Lechler RI, Batchelor JR: Restoration of immunogenicity to passenger cell-depleted kidney allografts by the addition of donor strain dendritic cells. J Exp Med 1982, 155:31-41
50. Benichou G, Takizawa PA, Olson CA, McMillan M, Sercarz EE: Donor major histocompatibility complex (MHC) peptides are presented by recipient MHC molecules during graft rejection. J Exp Med 1992, 175:305-308
51. Vella JP, Spadafora-Ferreira M, Murphy B, Alexander SI, Harmon W, Carpenter CB, Sayegh MH: Indirect allorecognition of major histocompatibility complex allopeptides in human renal transplant recipients with chronic graft dysfunction. Transplantation 1997, 64:795-800
52. Suciu-Foca N, Ciubotariu R, Itescu S, Rose EA, Cortesini R: Indirect allorecognition of donor HLA-DR peptides in chronic rejection of heart allografts. Transplant Proc 1998, 30:3999-4000
53. Baker RJ, Hernandez-Fuentes MP, Brookes PA, Chaudhry AN, Cook HT, Lechler RI: Loss of direct and maintenance of indirect alloresponses in renal allograft recipients: implications for the pathogenesis of chronic allograft nephropathy. J Immunol 2001, 167:7199-7206
54. Reznik SI, Jaramillo A, SivaSai KS, Womer KL, Sayegh MH, Trulock EP, Patterson GA, Mohanakumar T: Indirect allorecognition of mismatched donor HLA class II peptides in lung transplant recipients with bronchiolitis obliterans syndrome. Am J Transplant 2001, 1:228-235